BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10481575)

  • 1. [A new classification for the third millenium. When and until when?].
    Giralt M
    Sangre (Barc); 1999 Jun; 44(3):169-70. PubMed ID: 10481575
    [No Abstract]   [Full Text] [Related]  

  • 2. World Health Organization classification of the acute leukemias and myelodysplastic syndrome.
    Bennett JM
    Int J Hematol; 2000 Aug; 72(2):131-3. PubMed ID: 11039659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant lymphoma and leukemia concepts in new WHO classification].
    Kikuchi M
    Rinsho Byori; 2003 Aug; 51(8):820-4. PubMed ID: 13677944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of WHO classification for acute leukemia and myelodysplastic syndrome].
    Sugiura A; Takeshita A
    Rinsho Byori; 2006 Nov; 54(11):1178-86. PubMed ID: 17240841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myelodysplastic syndromes: classification and prognosis.
    Komrokji R; Bennett JM
    Curr Hematol Rep; 2003 May; 2(3):179-85. PubMed ID: 12901338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The World Health Organization (WHO) classification of the myeloid neoplasms.
    Vardiman JW; Harris NL; Brunning RD
    Blood; 2002 Oct; 100(7):2292-302. PubMed ID: 12239137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.
    Komrokji RS; Bennett JM
    Curr Hematol Rep; 2005 May; 4(3):175-81. PubMed ID: 15865868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new World Health Organization classification of myeloid neoplasms: Q&A with James W. Vardiman, MD.
    Vardiman JW
    Clin Adv Hematol Oncol; 2003 Jan; 1(1):18, 21. PubMed ID: 16227955
    [No Abstract]   [Full Text] [Related]  

  • 9. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
    Vardiman JW; Thiele J; Arber DA; Brunning RD; Borowitz MJ; Porwit A; Harris NL; Le Beau MM; Hellström-Lindberg E; Tefferi A; Bloomfield CD
    Blood; 2009 Jul; 114(5):937-51. PubMed ID: 19357394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correspondence re: Brunning R: Proposed WHO classification of acute myeloid leukemia and myelodysplastic syndromes. Mod Pathol 1999;1:102-4.
    Mazzella FM; Cotelingam JD; Kowal-Vern A; Shrit MA; Rector JT; Alvares C; Schumacher HR
    Mod Pathol; 2000 Jan; 13(1):101-2. PubMed ID: 10658917
    [No Abstract]   [Full Text] [Related]  

  • 11. The cytogenetics of haematological malignancies.
    Berger R
    Baillieres Clin Haematol; 1992 Oct; 5(4):791-814. PubMed ID: 1308165
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolving classifications of the myelodysplastic syndromes.
    Komrokji RS; Bennett JM
    Curr Opin Hematol; 2007 Mar; 14(2):98-105. PubMed ID: 17255786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)].
    Haferlach T; Schoch C
    Dtsch Med Wochenschr; 2002 Mar; 127(9):447-50. PubMed ID: 11870559
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of WHO classification and MDS 2000 classification in myelodysplastic syndromes].
    Akiba M; Matsuda A; Misumi M; Yagasaki F; Bessho M
    Rinsho Ketsueki; 2001 Dec; 42(12):1162-9. PubMed ID: 11828718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytomorphology of acute myeloid leukemia and myelodysplastic syndromes].
    Kuriyama K
    Rinsho Ketsueki; 2006 Aug; 47(8):701-9. PubMed ID: 16986708
    [No Abstract]   [Full Text] [Related]  

  • 16. [Overview of FAB/WHO classification and therapeutic modalities for myelodysplastic syndromes].
    Kanamaru A
    Rinsho Ketsueki; 2004 Apr; 45(4):261-7. PubMed ID: 15168440
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aggressive lymphomas: a convenient concept or an anatomo-pathological reality?].
    Pileri SA; Fraternali-Orcioni G; Ascani S; Piccioli M; Poggi S; Piccaluga PP; Leoncini L; Falini B
    Pathologica; 2000 Jun; 92(3):145-61. PubMed ID: 10902425
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
    Mufti GJ; Bennett JM; Goasguen J; Bain BJ; Baumann I; Brunning R; Cazzola M; Fenaux P; Germing U; Hellström-Lindberg E; Jinnai I; Manabe A; Matsuda A; Niemeyer CM; Sanz G; Tomonaga M; Vallespi T; Yoshimi A;
    Haematologica; 2008 Nov; 93(11):1712-7. PubMed ID: 18838480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Health Organization and international prognostic scoring system: the limitations of current classification systems in assessing prognosis and determining appropriate therapy in myelodysplastic syndromes.
    Schiffer CA
    Semin Hematol; 2008 Jan; 45(1):3-7. PubMed ID: 18179963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelomonocytic leukemia: lost in classification?
    Bowen DT
    Hematol Oncol; 2005 Mar; 23(1):26-33. PubMed ID: 16149105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.